Elsebeth Aagaard

Elsebeth Aagaard has extensive work experience in the field of regulatory and clinical affairs, as well as global clinical development. Elsebeth currently holds the position of Vice President, Regulatory and Clinical Affairs, Biosafety and Sustainability at Ambu A/S. Prior to this role, they served as the Senior Director of Global Clinical Affairs at the same company. Elsebeth also has experience working as a Director at Statens Serum Institut and holding various roles at ALK, including CMC Senior Project Manager, Manager of Aseptic Production, and Project Director of Global Project & Portfolio Management. Elsebeth Aagaard has also served as a Board Member at Sense, COO at Nanovi ApS, Consultant at CRUX-innovation, Vice President of Global R&D, Clinical & Regulatory Development at Coloplast, and as a Consultant at ClinConsult. Elsebeth also worked as a Medical Manager at Cartificial and as a Manager of Regulatory & Clinical Development at NatImmune.

Elsebeth Aagaard obtained a Master of Science in Pharmacy from Danmarks Farmaceutiske Universitet in 1989. Elsebeth later pursued a degree in HD1 from Copenhagen Business School from 1999 to 2001.